MARVIN S. HAUSMAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2002-04-29 Marvin S. Hausman, M.D. Age: 60 Director. Dr. Hausman has served since 1997, at various times, as a director and President and Chief Executive Officer of Axonyx, Inc., a public company listed on Nasdaq NM, and its predecessor, and currently serves in all three such positions. ... Dr. Hausman is a limited partner in Meridian which owns all 1,500,000 shares of the Companys Series F Preferred Stock issued and outstanding and a Common Stock purchase warrant for 1,500,000 shares (Dr. Hausmans limited partnership percentage interest is 3.3%). ...
2003-04-30 Marvin S. Hausman, M.D. Age: 61 Director. Dr. Hausman has served since 1997, at various times, as a director and President and Chief Executive Officer of Axonyx, Inc., a public company listed on Nasdaq NM, and its predecessor, and currently serves in all three such positions. ... The Company pays an annual fee of $4,000 to each non-employee director and an additional $1,000 to non-employee directors for serving as committee chair. During 2002, OXIS did not make payments under this policy. Payments will resume in 2003.

Data sourced from SEC filings. Last updated: 2025-08-30